PotBotics Issues Letter to Shareholders
Ryan Allway
March 23rd, 2019
News
NEW YORK, NY / ACCESSWIRE / March 22, 2019 / PotBotics, Inc. (“Company” or “PotBotics”), is pleased to provide its shareholders a letter of recent changes in preparation to go public.
Dear Shareholders,
In preparation for PotBotics’ going public transaction and in conjunction with its medical device registration, PotBotics plans to increase the size of its Board of Directors to five, with two independent directors (one from the U.S. and one from Canada), and appoint Mr. Greg Wagner as the Company’s Chief Executive Officer. Mr. Wagner is a former Wall Street veteran with over 20 years of experience in capital markets, and has extensive corporate, institutional and startup experience. Mr. Wagner is the former CEO of Aenoic Ventures, and was named innovator of the year in 2017, where he built, deployed and acquired new startups; advised startups and institutions in the implementation of ‘lean’ and ‘design’ thinking; and was actively involved in VC fundraising. Mr. Wagner is also former managing director, head of prime services and head of Institutional Sales at Itaú BBA Securities; and former managing director, head of equity prime services sales and trading at Royal Bank of Scotland. Mr. Wagner holds a certification in innovation and strategy from Harvard University, MBA in Finance from Fordham University and BA from University of Albany in Economics. Mr. Wagner also holds active licenses from Financial Industry Regulatory Authority (FINRA: 7, 63, 24, 55).
Mr. Wagner will be focusing on revenue generation and strategic partnerships, while guiding the Company’s investments in people, technology and achieving Ryah’s medical certification goals.
The Company plans to file a medical device applicant with the FDA in the U.S. and with Health Canada in the near future with the goal of becoming a leading company in the medical cannabis space. PotBotics remains the #1 application in the Apple Store for medical cannabis and our medical device – Ryah in U.S. and Canada.
Mr. Wagner commented, “I am honored to take on this role with such an industry-leading organization and plan to propel the Company forward as we look to ramp up the commercial efforts of Ryah. I look forward to bringing my extensive background in finance, management and operations to PotBotics, which is extremely important now as we prepare to be a publicly-traded company in Canada. I would like to thank David Goldstein for his role in leading the company over the last five years in the development of products and strategy, leading to its success positioning as we take the Company to the next level.”
If you have any questions, please direct your inquiries to Stephen Hart at hart@haydenir.com.
Best regards,
Baruch (Boris) Goldstein
Chairman and Co-Founder
PotBotics, Inc.
About PotBotics
PotBotics is a leading data aggregation and technology company focused on the global medical cannabis market. With a robust artificial intelligence platform that aggregates and correlates HIPAA-compliant medical data, PotBotics helps doctors and patients personalize cannabis to better predict treatment outcomes. Additionally, PotBotics will be releasing the world’s first dose-measuring vaporizer, Ryah. Ryah expects to provide unique insights on users’ consumption habits, cannabinoid research, and key business insights. With a strong IP portfolio for the industry’s most innovative products and services, PotBotics is able to gather insightful data on cannabis from seed to consumption.
Forward-Looking Statements
This release contains “forward-looking statements” that include information relating to future events and future financial and operating performance. The words “may,” “would,” “will,” “expect,” “estimate,” “can,” “believe,” “potential” and similar expressions and variations thereof are intended to identify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management’s good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause these differences include, but are not limited to: fluctuations in demand for Potbotics, Inc. products, the introduction of new products and market acceptance, the Company’s ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company’s liquidity and financial strength to support its growth, the success of the Company’s going-public transaction, and other information that may be detailed from time-to-time by Potbotics, Inc.. Potbotics, Inc. undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SOURCE: PotBotics
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Technical420 is the premier provider of research and analysis on cannabis stocks. We provide investors with sponsored and non-sponsored information on the volatile and emerging cannabis industry. “Our research is our passion!” Your profit is our reward!
Matt Hawkins is the founder and managing principal of Cresco Capital Partners, LLC (“Cresco”), a private equity firm focused specifically on investing in the legalized cannabis industry. Since its inception in the summer of 2015, Cresco has made 14 investments out of its first fund and is currently raising this fund, Fund II. Prior to the […]
Pascal Biosciences is a biotechnology company focused on advancing innovative approaches for the treatment of cancer including cannabinoid-based therapeutics and targeted therapies. The company’s leading cannabinoid portfolio comprises a small molecule therapeutic, ST-403, that is advancing into clinical trials for the treatment of glioblastoma, and an immuno-stimulatory molecule. In addition, Pascal Biosciences is developing a […]
IONIC BRANDS is a national cannabis holdings company based in Washington, led by a team of successful entrepreneurs.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
